SPAC Overview
Timeline Progress
- Registration2026-06-23 Filed S1
- IPO2026-08-06 IPO, search begins
- Definitive AgreementNo merger agreement yet
- CompletedNot yet completed
About
TCGX Acquisition Corp. is a blank-check company seeking an initial business combination, focusing on healthcare and healthcare-related industries, particularly life sciences and medical technology. It may also pursue a target located in Asia, including Hong Kong or the PRC.
Investment Focus
Healthcare, Biopharmaceuticals, Technology
Geographic Focus
Asia, Hong Kong, People’s Republic of China
The terms and the filing trail behind TCGX Acquisition Corp.
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
Led by Chen Yu, a healthcare investor and TCGX founder with more than two decades of healthcare investing, company-building and operating experience. The TCGX-affiliated team brings science-driven healthcare investment experience, including substantial experience in China.